Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP for Chronic Non-Healing Ulcers
NCT03026855Phase 1Completed
- Sponsor
- TotipotentRX
- Start
- Jun 2014
- Primary completion
- Apr 2016
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous platelet rich gel in chronic skin ulcer, sponsored by TotipotentRX. Primary endpoint: Number of Wound/ Ulcers Healed at 24 weeks. Started Jun 2014; status: completed.
02
Drugs
autologous platelet rich gel
03
Conditions
chronic skin ulcer
Beyond the preview
Go deeper on NCT03026855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03026855.